Skip to main content
Top
Published in: Breast Cancer Research 1/2016

Open Access 01-12-2016 | Research article

Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas

Authors: Elena López-Knowles, Qiong Gao, Maggie Chon U. Cheang, James Morden, Joel Parker, Lesley-Ann Martin, Isabel Pinhel, Fiona McNeill, Margaret Hills, Simone Detre, Maria Afentakis, Lila Zabaglo, Andrew Dodson, Anthony Skene, Chris Holcombe, John Robertson, Ian Smith, Judith M. Bliss, Mitch Dowsett, on behalf of the POETIC trialists

Published in: Breast Cancer Research | Issue 1/2016

Login to get access

Abstract

Background

Gene expression is widely used for the characterisation of breast cancers. Variability due to tissue heterogeneity or measurement error or systematic change due to peri-surgical procedures can affect measurements but is poorly documented. We studied the variability of global gene expression between core-cuts of primary ER+ breast cancers and the impact of delays to tissue stabilisation due to sample X-ray and of diagnostic core cutting.

Methods

Twenty-six paired core-cuts were taken immediately after tumour excision and up to 90 minutes delay due to sample X-ray; 57 paired core-cuts were taken at diagnosis and 2 weeks later at surgical excision. Whole genome expression analysis was conducted on extracted RNA. Correlations and differences were assessed between the expression of individual genes, gene sets/signatures and intrinsic subtypes.

Results

Twenty-three and 56 sample pairs, respectively, were suitable for analysis. The range of correlations for both sample sets were similar with the majority being >0.97 in both. Correlations between pairs for 18 commonly studied genes were also similar between the studies and mainly with Pearson correlation coefficients >0.6 except for a small number of genes, which had a narrow-dynamic range (e.g. MKI67, SNAI2). There was no systematic difference in intrinsic subtyping between the first and second sample of either set but there was c.15 % discordance between the subtype assignments between the pairs, mainly where the subtyping of individual samples was less certain. Increases in the expression of several stress/early-response genes (e.g. FOS, FOSB, JUN) were found in both studies and confirmed findings in earlier smaller studies. Increased expression of IL6, IGFBP2 and MYC (by 17 %, 14 % and 44 %, respectively) occurred between the samples taken 2 weeks apart and again confirmed findings from an earlier study.

Conclusions

There is generally good correlation in gene expression between pairs of core-cuts except where genes have a narrow dynamic range. Similar correlation coefficients to the average gene expression profiles of intrinsic subtype, particularly LumA and LumB, can lead to discordances between assigned subtypes. Substantial changes in expression of early-response genes occur within an hour after surgery and in IL6, IGFB2 and MYC as a result of diagnostic core-cut biopsy.

Trial registration

Trial number CRUK/​07/​015. Study start date September 2008.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dowsett M, Smith I, Robertson J, Robison L, Pinhel I, Johnson L, et al. Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer. J Natl Cancer Inst Monogr. 2011;2011(43):120–3.CrossRefPubMed Dowsett M, Smith I, Robertson J, Robison L, Pinhel I, Johnson L, et al. Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer. J Natl Cancer Inst Monogr. 2011;2011(43):120–3.CrossRefPubMed
2.
go back to reference Pinhel IF, MacNeill FA, Hills MJ, Salter J, Detre S, A'Hern R, et al. Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer. Breast Cancer Res. 2010;12(5):R76.CrossRefPubMedPubMedCentral Pinhel IF, MacNeill FA, Hills MJ, Salter J, Detre S, A'Hern R, et al. Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer. Breast Cancer Res. 2010;12(5):R76.CrossRefPubMedPubMedCentral
3.
go back to reference De Cecco L, Musella V, Veneroni S, Cappelletti V, Bongarzone I, Callari M, et al. Impact of biospecimens handling on biomarker research in breast cancer. BMC Cancer. 2009;9:409.CrossRefPubMedPubMedCentral De Cecco L, Musella V, Veneroni S, Cappelletti V, Bongarzone I, Callari M, et al. Impact of biospecimens handling on biomarker research in breast cancer. BMC Cancer. 2009;9:409.CrossRefPubMedPubMedCentral
4.
go back to reference Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, et al. Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue. Mol Oncol. 2011;5(6):564–76.CrossRefPubMed Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, et al. Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue. Mol Oncol. 2011;5(6):564–76.CrossRefPubMed
5.
go back to reference Aktas B, Sun H, Yao H, Shi W, Hubbard R, Zhang Y, et al. Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue. Mol Oncol. 2014;8(3):717–27.CrossRefPubMedPubMedCentral Aktas B, Sun H, Yao H, Shi W, Hubbard R, Zhang Y, et al. Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue. Mol Oncol. 2014;8(3):717–27.CrossRefPubMedPubMedCentral
6.
go back to reference Jeselsohn RM, Werner L, Regan MM, Fatima A, Gilmore L, Collins LC, et al. Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response. PLoS One. 2013;8(5):e64225.CrossRefPubMedPubMedCentral Jeselsohn RM, Werner L, Regan MM, Fatima A, Gilmore L, Collins LC, et al. Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response. PLoS One. 2013;8(5):e64225.CrossRefPubMedPubMedCentral
7.
go back to reference Riis ML, Luders T, Markert EK, Haakensen VD, Nesbakken AJ, Kristensen VN, et al. Molecular profiles of pre- and postoperative breast cancer tumours reveal differentially expressed genes. ISRN Oncol. 2012;2012:450267.PubMedPubMedCentral Riis ML, Luders T, Markert EK, Haakensen VD, Nesbakken AJ, Kristensen VN, et al. Molecular profiles of pre- and postoperative breast cancer tumours reveal differentially expressed genes. ISRN Oncol. 2012;2012:450267.PubMedPubMedCentral
8.
go back to reference Wong V, Wang DY, Warren K, Kulkarni S, Boerner S, Done SJ, et al. The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers. BMC Cancer. 2008;8:277.CrossRefPubMedPubMedCentral Wong V, Wang DY, Warren K, Kulkarni S, Boerner S, Done SJ, et al. The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers. BMC Cancer. 2008;8:277.CrossRefPubMedPubMedCentral
9.
go back to reference Dunbier AK, Ghazoui Z, Anderson H, Salter J, Nerurkar A, Osin P, et al. Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistance. Clin Cancer Res. 2013; 19(10):2775–86.CrossRefPubMed Dunbier AK, Ghazoui Z, Anderson H, Salter J, Nerurkar A, Osin P, et al. Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistance. Clin Cancer Res. 2013; 19(10):2775–86.CrossRefPubMed
10.
go back to reference Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sorlie T, et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A. 2005;102(10):3738–43.CrossRefPubMedPubMedCentral Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sorlie T, et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A. 2005;102(10):3738–43.CrossRefPubMedPubMedCentral
11.
go back to reference Fisher RA. Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population. Biometrika. 1915;10(4):507–21. Fisher RA. Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population. Biometrika. 1915;10(4):507–21.
12.
go back to reference Dethlefsen C, Hojfeldt G, Hojman P. The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res Treat. 2013;138(3):657–64.CrossRefPubMed Dethlefsen C, Hojfeldt G, Hojman P. The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res Treat. 2013;138(3):657–64.CrossRefPubMed
13.
go back to reference Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100(14):8418–23.CrossRefPubMedPubMedCentral Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100(14):8418–23.CrossRefPubMedPubMedCentral
14.
go back to reference Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24(9):2206–23. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24(9):2206–23.
Metadata
Title
Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas
Authors
Elena López-Knowles
Qiong Gao
Maggie Chon U. Cheang
James Morden
Joel Parker
Lesley-Ann Martin
Isabel Pinhel
Fiona McNeill
Margaret Hills
Simone Detre
Maria Afentakis
Lila Zabaglo
Andrew Dodson
Anthony Skene
Chris Holcombe
John Robertson
Ian Smith
Judith M. Bliss
Mitch Dowsett
on behalf of the POETIC trialists
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2016
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-016-0696-2

Other articles of this Issue 1/2016

Breast Cancer Research 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine